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Michael IbbaMichael Ibba is Professor and Director of the Biochemistry
Graduate Program at Ohio State University, and a member of the
FEBS Letters Editorial Board since 2008. An Englishman of Italian ori-
gins, Ibba reﬂects his cultural background by being an eloquent and
passionate scientist with a friendly and good-natured demeanor.
We have had the pleasure to interview Professor Ibba in order to
give our readers and authors an idea ofwho is handlingmanuscripts
in the ﬁelds of RNA, protein synthesis and translation at FEBS Letters.
What does your research currently focus on?
We are interested in the translation-related stratagems that
bacteria develop in order to evade stress and increase survival.
One of these consists in making mistakes in protein synthesis
[1]. Several microorganisms increase their error rate under stress
to enhance morphological diversity and to be able to colonize
and survive in more diverse niches. We focus on the errors that
take place before the ribosome and cannot be corrected by the
ribosome. We also study the ability of some bacteria to divert ami-
no acids away from protein synthesis and use them to develop
antibiotic resistance. For example, some pathogens can snatch ly-
sines from tRNAs and attach them to the phosphatidylglycerol of
membrane phospholipids in order to invert the charge of the lipids.
This way the positive charge of the lysines will repel cationic anti-
microbial peptides.
Another interesting mechanism involves a protein called elon-
gation factor P (EF-P) that mimics a transfer RNA in its shape and
size, but is in fact a protein. EF-P can be aminoacylated by a speciﬁc
lysyl-tRNA synthetase that has lost its tRNA binding domain. Once
the lysine is attached, the protein is thought to occupy the E site of
the ribosome and speed up the synthesis of polyproline stretches,
which are typically found in Salmonella virulence factors and are
normally translated at a slow rate.
Which is your favorite among your numerous publications?
During my postdoc in Dieter Söll’s lab at Yale, some of us were
asked to look for missing essential components of the translation
machinery in archaea. I set out to look for an aminoacyl tRNA syn-
thetase starting from a very small amount of cells. The project was
very exciting, fun, and it simply worked right away. I can still
remember the thrill I felt looking at a band on the gel correspond-0014-5793/$36.00  2013 Federation of European Biochemical Societies. Published by E
http://dx.doi.org/10.1016/j.febslet.2013.07.001ing to a protein that no one else had ever seen before! We pub-
lished this in Science, and it is one of my favorite papers [2].
As an author, what feature do you like in a scientiﬁc journal?
I like a balanced editorial process that is not subject to fashion
or to editorial whims, and I like getting a clean, reliable decision
that you can respect at the end of the process. Once, I found out
after one of my papers got rejected that we never saw one of the
reviews, the editor had kept it away. I like a journal to be honest
and transparent.
I think that the reason why we get so little negative feedback
from authors who get rejected in FEBS Letters is because we treat
them with respect and we do our best to give the authors a clear,
balanced and fair experience.
What, in your opinion, are the main assets of FEBS Letters?
One is reliability, as I just mentioned. I also think that the lim-
ited length of FEBS Letters articles is a good format, which allows
you to make neat and discreet points. You don’t need to drown
people in data to convince them about something. There’s a paper
that I published in FEBS Letters in the mid nineties, which keeps on
getting cited, and it’s a very simple, to the point paper that JBC re-
jected! We just shortened it, made it cleaner and sent it to FEBS
Letters.
Is there anything you would change about your work?
Actually, I am the one who is in constant transformation. A big
change (and challenge) came when I ﬁrst became an independent
investigator in Denmark. At the time I thought I could go on like
when I was a postdoc. Gradually, I became less naïve, and learned
to reconﬁgure how I did everything and think like a PI. I learned a
lot on how to run a lab from my mentors, Hauke Hennecke and
Dieter Söll.
Things became easier since I am at Ohio State University.
There’s a big RNA community here and the atmosphere is great.
The only person you can blame for not being successful here is
yourself. Nevertheless, another change came recently, when I
was elected member of the American Academy of Microbiology
and Chair of our Microbiology Department. I am a biochemist bylsevier B.V. All rights reserved.
2290 Editorial / FEBS Letters 587 (2013) 2289–2290training, and never thought I would be a microbiologist, though
now I can’t deny it!
Experience has taught me to be less headstrong, and that ﬂexi-
bility or the capacity to change with times is important.
Where would we typically ﬁnd you on a weekend?
I would probably be at the farmers market, or in my garden,
barbequing with my kids and lots of friends.
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